Delivery Order SPE2DR25D3103-SPE2DR26F9T28
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $11,236.71. This firm fixed-price delivery order represents a competitive, non-set-aside award and is scheduled for completion by November 24, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a $44,846.76 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Tagrisso 80 mg tablets in quantities of 30 units. This is a firm fixed-price contract with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract ceiling value of $22,473.42. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed price contract. The award was made on December 22, 2025, with an ultimate completion date of January 14, 2026, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units. This Firm Fixed Price delivery order carries a ceiling value of $10,662.57 and is scheduled for completion by August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Tagrisso 40 mg tablets (30-count) with a ceiling value of $11,214.04. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. The order is scheduled for completion by December 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units, with a contract ceiling value of $11,236.71. This is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency has awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract value of $21,325.16. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by November 19, 2025, with performance conducted at the...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9T28Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Tagrisso 80 mg tablets in quantities of 30, with a ceiling value of $11,236.71. This firm fixed-price delivery order is expected to be completed by January 22, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is unclassified as a set-aside contract and represents a competitive award to AmerisourceBergen, one of the nation's largest pharmaceutical distributors. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical Supply Chain relies on AmerisourceBergen as a prime vendor for critical pharmaceutical products, including specialty medications, brand-name and generic drugs, and vaccines, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 12/29/25 |